share_log

HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Down 84.1% in November

HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Down 84.1% in November

HAVN Life Sciences Inc.(OTCMKTS: HAVLF)11月份空头利率下降了84.1%
kopsource ·  2022/12/12 21:41

HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) saw a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 2,400 shares, a decline of 84.1% from the November 15th total of 15,100 shares. Based on an average daily trading volume, of 24,500 shares, the days-to-cover ratio is currently 0.1 days.

11月份,HAvn Life Science Inc.(场外市场代码:HAVLF-GET Rating)的空头股数销量大幅下降。截至11月30日,空头股数共有2400股,比11月15日的15100股下降了84.1%。以日均成交量24,500股计算,目前天数与回补比率为0.1天。

HAVN Life Sciences Price Performance

拥有生命科学的性价比

OTCMKTS HAVLF traded down $0.00 on Monday, reaching $0.05. The stock had a trading volume of 327 shares, compared to its average volume of 5,594. HAVN Life Sciences has a 12-month low of $0.05 and a 12-month high of $4.96. The business's 50-day moving average price is $0.07 and its 200 day moving average price is $0.59.

周一,OTCMKTS HAVLF股价下跌0.00美元,至0.05美元。该股成交量为327股,而其平均成交量为5594股。HAvn Life Sciences的股价为0.05美元,为12个月低点,12个月高位为4.96美元。该业务的50日移动均线价格为0.07美元,200日移动均线价格为0.59美元。

Get
到达
HAVN Life Sciences
拥有生命科学学位
alerts:
警报:

About HAVN Life Sciences

关于HAVN生命科学

(Get Rating)

(获取评级)

HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.
HAVN生命科学公司是一家生物技术公司,从事从植物和真菌中提取的精神药理产品的研究和开发。该公司还专注于开发从植物和真菌(包括裸子菌属)中标准化和质量控制地提取精神活性化合物的方法。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
  • Three Small-Cap Biotech Stocks to Consider Now
  • Two Blue Chip Health Companies The Institutions Are Buying
  • What To Expect From The Q4 Earnings Reporting Season
  • Here's What to Expect for the S&P 500 in 2023
  • Can Bilibili be the Chinese Version of YouTube?
  • 免费获取StockNews.com关于HAVN生命科学的研究报告(HAVLF)
  • 现在要考虑的三只小盘生物科技股
  • 这两家机构正在收购的两家蓝筹健康公司
  • 第四季度财报季的预期是什么
  • 以下是对2023年标准普尔500指数的预期
  • 哔哩哔哩能成为中国版的YouTube吗?

Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

接受《HAVN生命科学日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对HAVN生命科学和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发